Cover story
Restarting a Manufacturing Campus and Revitalizing a Community
Adam Covitt
Federal Equipment Company
PAP-Q3-20-CL-016Sep 30, 2020
Nice Insight Overview
The Benefits of Expanding OSD Capacity
Nigel Walker
Nice Insight
PAP-Q3-20-NI-001Sep 29, 2020
Equipment
Reshoring a Nation’s API and Pharmaceutical Production
Matt Hicks
Federal Equipment Company
PAP-Q3-20-CL-015Sep 29, 2020
Microbiome CDMO
Extensive Experience Is Crucial to Speed to the Clinic and Market for Live Biotherapeutic Products
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAP-Q3-20-CL-004Sep 29, 2020
Vaccine Distribution
Anticipating the Logistics of a COVID-19 Vaccination Effort
Andrew Boyle; Marc Boyle; Patrick Schafer
Boyle Transportation
PAP-Q3-20-CL-010Sep 29, 2020
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
Nicholas Green
Avid Bioservices
PAP-Q3-20-CL-008Sep 29, 2020
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018Sep 29, 2020
Integrated CDMO
Building an Integrated and Effective CDMO from the Ground Up
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q3-20-CL-027Sep 29, 2020
Recombinant Proteins
Innovation and Flexibility Drive Success During the COVID-19 Pandemic
Paul Magreta
Grifols Recombinant Protein CDMO
PAP-Q3-20-CL-019Sep 29, 2020
Decentralized Trials
Facilitating the Full Spectrum of Decentralized Trials
Mamta Trivedi
Biorasi
PAP-Q3-20-CL-009Sep 29, 2020
Northern Ireland
COVID-19 and the Growing Need for Dual-Source Supply Chains
Kevin Holland
PAP-Q3-20-CL-022Sep 29, 2020
Decentralized Trials
Protecting Clinical Research and Patients Through Decentralized Trial Strategies
Brittany Erana; Alistair Davidson
PPD clinical research business of Thermo Fisher Scientific
PAP-Q3-20-CL-025Sep 29, 2020
Lipid Excipients
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
Adela Kasselkus, Ph.D.; Shiksha Mantri, Ph.D.
MilliporeSigma
PAP-Q3-20-CL-024Sep 29, 2020
Organ-on-a-Chip
Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models
Gustavo Mahler, Ph.D.; Jessica Davis
Dynamk Capital
PAP-Q3-20-CL-014Sep 29, 2020
Bioanalysis
How Bioanalysis Supports the Development of New Cell and Gene Therapies
Timothy Sangster
Celerion
PAP-Q3-20-CL-012Sep 29, 2020
Pharma/Biotech Advising
Data-Driven Decision-Making Throughout the Pharma Life Cycle
Stephan Kutzer, Ph.D.; Danielle A. Young
AKDYS
PAP-Q3-20-CL-001Sep 29, 2020
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
Peter Soelkner; Frank Mathias, Ph.D.
Vetter Pharma International GmbH
PAP-Q3-20-CL-028Sep 29, 2020
CRISPR RNPs
CRISPR RNPs and the Future of Cell and Gene Therapy
Thomas Lynch, Ph.D.
Aldevron
PAP-Q3-20-CL-002Sep 29, 2020
Supply Chain
Introduction: The Evolving Pharmaceutical Supply
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-12Sep 29, 2020
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-002Sep 29, 2020